Autor: |
Kumar, Vikneswary Ravi, Kampan, Nirmala Chandralega, Abd Aziz, Nor Haslinda, Teik, Chew Kah, Shafiee, Mohamad Nasir, Menon, P. Susthitha |
Předmět: |
|
Zdroj: |
Cancers; Dec2023, Vol. 15 Issue 23, p5607, 26p |
Abstrakt: |
Simple Summary: This review significantly contributes to the research community by providing insights into the role of serum-based biomarkers for the diagnosis of ovarian cancer. It also provides a comprehensive overview of recent advancements in immunoassay detection and employing multiplex technology and SPR biosensors to identify CA125 and HE4 biomarkers. Furthermore, it addresses the challenges associated with these diagnostic methods. This valuable information not only enhances our understanding of ovarian cancer diagnosis but also serves as a reference point for researchers and clinicians working in the field, facilitating further advancements and improvements in early detection methods. Epithelial Ovarian Cancer (EOC) is a leading cause of cancer-related deaths among women, mainly due to a lack of early detection and screening methods. Advanced immunoassay techniques, such as Luminex and proximity extension assay (PEA) technology, show promise in improving EOC detection by utilizing highly sensitive and specific multiplex panels to detect multiple combinations of biomarkers. However, these advanced immunoassay techniques have certain limitations, especially in validating the performance characteristics such as specificity, sensitivity, limit of detection (LOD), and dynamic range for each EOC biomarker within the panel. Implementing multiplexing in point-of-care (POC) biosensors can enhance EOC biomarker detection, with Surface Plasmon Resonance (SPR) being a versatile option among optical biosensors. There is no study on multiplex SPR biosensors specifically tailored for diagnosing EOC. Recent studies have shown promising results in the single detection of EOC biomarkers using SPR, with LOD for cancer antigen 125 (CA125) at 0.01 U/mL−1 and human epididymis protein 4 (HE4) at 1pM. This study proposes a potential roadmap for scientists and engineers in academia and industry to develop a cost effective yet highly efficient SPR biosensor platform for detecting EOC. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|